nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—ALB—acquired immunodeficiency syndrome	0.233	1	CbGaD
Captopril—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.0691	0.148	CbGbCtD
Captopril—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.0523	0.112	CbGbCtD
Captopril—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.0275	0.059	CbGbCtD
Captopril—ALB—Saquinavir—acquired immunodeficiency syndrome	0.0244	0.0524	CbGbCtD
Captopril—ALB—Zidovudine—acquired immunodeficiency syndrome	0.0234	0.0502	CbGbCtD
Captopril—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.0213	0.0456	CbGbCtD
Captopril—REN—Metabolism of Angiotensinogen to Angiotensins—ENPEP—acquired immunodeficiency syndrome	0.0189	0.276	CbGpPWpGaD
Captopril—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0187	0.0401	CbGbCtD
Captopril—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0186	0.04	CbGbCtD
Captopril—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0176	0.0377	CbGbCtD
Captopril—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0176	0.0377	CbGbCtD
Captopril—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0169	0.0362	CbGbCtD
Captopril—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0159	0.0341	CbGbCtD
Captopril—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0159	0.0341	CbGbCtD
Captopril—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0145	0.0312	CbGbCtD
Captopril—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0141	0.0303	CbGbCtD
Captopril—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0137	0.0294	CbGbCtD
Captopril—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0133	0.0286	CbGbCtD
Captopril—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0128	0.0274	CbGbCtD
Captopril—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0128	0.0274	CbGbCtD
Captopril—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0122	0.0263	CbGbCtD
Captopril—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.012	0.0258	CbGbCtD
Captopril—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.012	0.0258	CbGbCtD
Captopril—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00947	0.0203	CbGbCtD
Captopril—ACE—Metabolism of Angiotensinogen to Angiotensins—ENPEP—acquired immunodeficiency syndrome	0.00844	0.123	CbGpPWpGaD
Captopril—REN—Peptide hormone metabolism—ENPEP—acquired immunodeficiency syndrome	0.00497	0.0726	CbGpPWpGaD
Captopril—REN—nerve—acquired immunodeficiency syndrome	0.00346	0.0465	CbGeAlD
Captopril—MMP2—endothelium—acquired immunodeficiency syndrome	0.00271	0.0364	CbGeAlD
Captopril—REN—blood plasma—acquired immunodeficiency syndrome	0.00262	0.0352	CbGeAlD
Captopril—MMP2—blood plasma—acquired immunodeficiency syndrome	0.00241	0.0323	CbGeAlD
Captopril—MMP9—endothelium—acquired immunodeficiency syndrome	0.00236	0.0316	CbGeAlD
Captopril—ACE—Peptide hormone metabolism—ENPEP—acquired immunodeficiency syndrome	0.00222	0.0324	CbGpPWpGaD
Captopril—MMP9—blood plasma—acquired immunodeficiency syndrome	0.00209	0.0281	CbGeAlD
Captopril—F2—endothelium—acquired immunodeficiency syndrome	0.00206	0.0276	CbGeAlD
Captopril—LTA4H—retina—acquired immunodeficiency syndrome	0.00186	0.0249	CbGeAlD
Captopril—F2—blood plasma—acquired immunodeficiency syndrome	0.00183	0.0245	CbGeAlD
Captopril—ACE—nerve—acquired immunodeficiency syndrome	0.00148	0.0198	CbGeAlD
Captopril—F2—FOXA2 and FOXA3 transcription factor networks—TAT—acquired immunodeficiency syndrome	0.00143	0.0209	CbGpPWpGaD
Captopril—LTA4H—lymphoid tissue—acquired immunodeficiency syndrome	0.00132	0.0177	CbGeAlD
Captopril—MMP2—retina—acquired immunodeficiency syndrome	0.00132	0.0177	CbGeAlD
Captopril—LTA4H—digestive system—acquired immunodeficiency syndrome	0.0013	0.0175	CbGeAlD
Captopril—ACE—endothelium—acquired immunodeficiency syndrome	0.00126	0.0169	CbGeAlD
Captopril—LTA4H—blood—acquired immunodeficiency syndrome	0.00124	0.0167	CbGeAlD
Captopril—LTA4H—bone marrow—acquired immunodeficiency syndrome	0.0012	0.0161	CbGeAlD
Captopril—LTA4H—spinal cord—acquired immunodeficiency syndrome	0.0012	0.0161	CbGeAlD
Captopril—MMP2—skin of body—acquired immunodeficiency syndrome	0.00116	0.0155	CbGeAlD
Captopril—LTA4H—vagina—acquired immunodeficiency syndrome	0.00115	0.0155	CbGeAlD
Captopril—ACE—blood plasma—acquired immunodeficiency syndrome	0.00112	0.015	CbGeAlD
Captopril—LTA4H—lung—acquired immunodeficiency syndrome	0.00109	0.0146	CbGeAlD
Captopril—LTA4H—nervous system—acquired immunodeficiency syndrome	0.00101	0.0135	CbGeAlD
Captopril—REN—digestive system—acquired immunodeficiency syndrome	0.00101	0.0135	CbGeAlD
Captopril—MMP9—skin of body—acquired immunodeficiency syndrome	0.00101	0.0135	CbGeAlD
Captopril—LTA4H—central nervous system—acquired immunodeficiency syndrome	0.000971	0.013	CbGeAlD
Captopril—REN—blood—acquired immunodeficiency syndrome	0.000959	0.0129	CbGeAlD
Captopril—REN—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000938	0.0137	CbGpPWpGaD
Captopril—MMP2—lymphoid tissue—acquired immunodeficiency syndrome	0.000937	0.0126	CbGeAlD
Captopril—MMP2—digestive system—acquired immunodeficiency syndrome	0.000926	0.0124	CbGeAlD
Captopril—MMP2—EPH-Ephrin signaling—ACTG1—acquired immunodeficiency syndrome	0.000907	0.0132	CbGpPWpGaD
Captopril—MMP2—Syndecan-2-mediated signaling events—CSF2—acquired immunodeficiency syndrome	0.000887	0.013	CbGpPWpGaD
Captopril—MMP2—blood—acquired immunodeficiency syndrome	0.000882	0.0118	CbGeAlD
Captopril—MMP9—Syndecan-4-mediated signaling events—CXCL12—acquired immunodeficiency syndrome	0.000853	0.0125	CbGpPWpGaD
Captopril—MMP9—Syndecan-4-mediated signaling events—CXCR4—acquired immunodeficiency syndrome	0.000853	0.0125	CbGpPWpGaD
Captopril—MMP2—spinal cord—acquired immunodeficiency syndrome	0.000849	0.0114	CbGeAlD
Captopril—REN—lung—acquired immunodeficiency syndrome	0.000841	0.0113	CbGeAlD
Captopril—MMP2—vagina—acquired immunodeficiency syndrome	0.000817	0.011	CbGeAlD
Captopril—MMP9—lymphoid tissue—acquired immunodeficiency syndrome	0.000815	0.0109	CbGeAlD
Captopril—MMP9—digestive system—acquired immunodeficiency syndrome	0.000805	0.0108	CbGeAlD
Captopril—REN—nervous system—acquired immunodeficiency syndrome	0.000779	0.0105	CbGeAlD
Captopril—MMP2—lung—acquired immunodeficiency syndrome	0.000773	0.0104	CbGeAlD
Captopril—LTA4H—brain—acquired immunodeficiency syndrome	0.000771	0.0104	CbGeAlD
Captopril—MMP9—blood—acquired immunodeficiency syndrome	0.000767	0.0103	CbGeAlD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000753	0.011	CbGpPWpGaD
Captopril—REN—central nervous system—acquired immunodeficiency syndrome	0.00075	0.0101	CbGeAlD
Captopril—LTA4H—lymph node—acquired immunodeficiency syndrome	0.000745	0.01	CbGeAlD
Captopril—MMP9—bone marrow—acquired immunodeficiency syndrome	0.000742	0.00996	CbGeAlD
Captopril—MMP9—spinal cord—acquired immunodeficiency syndrome	0.000739	0.00992	CbGeAlD
Captopril—MMP2—nervous system—acquired immunodeficiency syndrome	0.000716	0.00961	CbGeAlD
Captopril—F2—lymphoid tissue—acquired immunodeficiency syndrome	0.000711	0.00955	CbGeAlD
Captopril—F2—digestive system—acquired immunodeficiency syndrome	0.000702	0.00943	CbGeAlD
Captopril—MMP2—central nervous system—acquired immunodeficiency syndrome	0.000689	0.00925	CbGeAlD
Captopril—MMP9—lung—acquired immunodeficiency syndrome	0.000672	0.00903	CbGeAlD
Captopril—F2—blood—acquired immunodeficiency syndrome	0.000669	0.00898	CbGeAlD
Captopril—F2—Syndecan-4-mediated signaling events—CXCR4—acquired immunodeficiency syndrome	0.000659	0.00962	CbGpPWpGaD
Captopril—F2—Syndecan-4-mediated signaling events—CXCL12—acquired immunodeficiency syndrome	0.000659	0.00962	CbGpPWpGaD
Captopril—MMP9—Syndecan-4-mediated signaling events—CCL5—acquired immunodeficiency syndrome	0.000649	0.00948	CbGpPWpGaD
Captopril—F2—bone marrow—acquired immunodeficiency syndrome	0.000647	0.00869	CbGeAlD
Captopril—F2—spinal cord—acquired immunodeficiency syndrome	0.000645	0.00866	CbGeAlD
Captopril—MMP9—nervous system—acquired immunodeficiency syndrome	0.000623	0.00836	CbGeAlD
Captopril—MMP9—central nervous system—acquired immunodeficiency syndrome	0.000599	0.00805	CbGeAlD
Captopril—SLC15A1—digestive system—acquired immunodeficiency syndrome	0.000598	0.00804	CbGeAlD
Captopril—REN—brain—acquired immunodeficiency syndrome	0.000595	0.00799	CbGeAlD
Captopril—MMP9—EPH-Ephrin signaling—ACTG1—acquired immunodeficiency syndrome	0.000595	0.00868	CbGpPWpGaD
Captopril—F2—lung—acquired immunodeficiency syndrome	0.000587	0.00788	CbGeAlD
Captopril—ALB—FOXA2 and FOXA3 transcription factor networks—TAT—acquired immunodeficiency syndrome	0.000568	0.00829	CbGpPWpGaD
Captopril—MMP9—Syndecan-1-mediated signaling events—CCL5—acquired immunodeficiency syndrome	0.000566	0.00826	CbGpPWpGaD
Captopril—MMP2—brain—acquired immunodeficiency syndrome	0.000547	0.00735	CbGeAlD
Captopril—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000546	0.00733	CbGeAlD
Captopril—F2—nervous system—acquired immunodeficiency syndrome	0.000543	0.00729	CbGeAlD
Captopril—MMP2—lymph node—acquired immunodeficiency syndrome	0.000529	0.0071	CbGeAlD
Captopril—SLC15A1—vagina—acquired immunodeficiency syndrome	0.000528	0.0071	CbGeAlD
Captopril—F2—central nervous system—acquired immunodeficiency syndrome	0.000523	0.00702	CbGeAlD
Captopril—MMP9—TWEAK Signaling Pathway—CCL5—acquired immunodeficiency syndrome	0.000522	0.00763	CbGpPWpGaD
Captopril—F2—Syndecan-4-mediated signaling events—CCL5—acquired immunodeficiency syndrome	0.000501	0.00732	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.000498	0.00727	CbGpPWpGaD
Captopril—MMP9—IL1 and megakaryotyces in obesity—IFNG—acquired immunodeficiency syndrome	0.000479	0.00699	CbGpPWpGaD
Captopril—MMP9—brain—acquired immunodeficiency syndrome	0.000476	0.00639	CbGeAlD
Captopril—MMP2—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000466	0.0068	CbGpPWpGaD
Captopril—MMP9—lymph node—acquired immunodeficiency syndrome	0.00046	0.00617	CbGeAlD
Captopril—ACE—lymphoid tissue—acquired immunodeficiency syndrome	0.000434	0.00583	CbGeAlD
Captopril—ACE—digestive system—acquired immunodeficiency syndrome	0.000429	0.00576	CbGeAlD
Captopril—SLC22A6—brain—acquired immunodeficiency syndrome	0.000425	0.00571	CbGeAlD
Captopril—ACE—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000419	0.00612	CbGpPWpGaD
Captopril—F2—brain—acquired immunodeficiency syndrome	0.000415	0.00558	CbGeAlD
Captopril—ACE—blood—acquired immunodeficiency syndrome	0.000409	0.00549	CbGeAlD
Captopril—ACE—bone marrow—acquired immunodeficiency syndrome	0.000395	0.00531	CbGeAlD
Captopril—MMP2—Matrix Metalloproteinases—TNF—acquired immunodeficiency syndrome	0.000395	0.00577	CbGpPWpGaD
Captopril—MMP9—CXCR4-mediated signaling events—CXCR4—acquired immunodeficiency syndrome	0.000394	0.00576	CbGpPWpGaD
Captopril—MMP9—CXCR4-mediated signaling events—CXCL12—acquired immunodeficiency syndrome	0.000394	0.00576	CbGpPWpGaD
Captopril—LTA4H—Metabolism—TAT—acquired immunodeficiency syndrome	0.000394	0.00576	CbGpPWpGaD
Captopril—ACE—spinal cord—acquired immunodeficiency syndrome	0.000394	0.00529	CbGeAlD
Captopril—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000393	0.00527	CbGeAlD
Captopril—MMP2—amb2 Integrin signaling—TNF—acquired immunodeficiency syndrome	0.000375	0.00548	CbGpPWpGaD
Captopril—F2—IL1 and megakaryotyces in obesity—IFNG—acquired immunodeficiency syndrome	0.00037	0.0054	CbGpPWpGaD
Captopril—ACE—lung—acquired immunodeficiency syndrome	0.000358	0.00481	CbGeAlD
Captopril—MMP2—ATF-2 transcription factor network—IFNG—acquired immunodeficiency syndrome	0.000355	0.00519	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—IL10—acquired immunodeficiency syndrome	0.000346	0.00505	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	0.000345	0.00504	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—CSF2—acquired immunodeficiency syndrome	0.000342	0.00499	CbGpPWpGaD
Captopril—MMP2—Axon guidance—ACTG1—acquired immunodeficiency syndrome	0.000337	0.00492	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—IL4—acquired immunodeficiency syndrome	0.000336	0.00491	CbGpPWpGaD
Captopril—LTA4H—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000335	0.00489	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000334	0.00488	CbGpPWpGaD
Captopril—ACE—nervous system—acquired immunodeficiency syndrome	0.000332	0.00446	CbGeAlD
Captopril—MMP9—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	0.00032	0.00467	CbGpPWpGaD
Captopril—ACE—central nervous system—acquired immunodeficiency syndrome	0.000319	0.00429	CbGeAlD
Captopril—F2—Regulation of Actin Cytoskeleton—ACTG1—acquired immunodeficiency syndrome	0.000318	0.00464	CbGpPWpGaD
Captopril—MMP2—amb2 Integrin signaling—IL6—acquired immunodeficiency syndrome	0.000303	0.00442	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.000302	0.0044	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.000273	0.00398	CbGpPWpGaD
Captopril—F2—Folate Metabolism—IL4—acquired immunodeficiency syndrome	0.000272	0.00397	CbGpPWpGaD
Captopril—MMP2—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—acquired immunodeficiency syndrome	0.00027	0.00394	CbGpPWpGaD
Captopril—ALB—brain—acquired immunodeficiency syndrome	0.000265	0.00356	CbGeAlD
Captopril—MMP2—Angiopoietin receptor Tie2-mediated signaling—TNF—acquired immunodeficiency syndrome	0.000263	0.00383	CbGpPWpGaD
Captopril—MMP9—Matrix Metalloproteinases—TNF—acquired immunodeficiency syndrome	0.000259	0.00378	CbGpPWpGaD
Captopril—ALB—lymph node—acquired immunodeficiency syndrome	0.000256	0.00344	CbGeAlD
Captopril—F2—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000254	0.00371	CbGpPWpGaD
Captopril—ACE—brain—acquired immunodeficiency syndrome	0.000254	0.00341	CbGeAlD
Captopril—F2—FOXA2 and FOXA3 transcription factor networks—ALB—acquired immunodeficiency syndrome	0.000249	0.00364	CbGpPWpGaD
Captopril—MMP9—amb2 Integrin signaling—TNF—acquired immunodeficiency syndrome	0.000246	0.00359	CbGpPWpGaD
Captopril—ACE—lymph node—acquired immunodeficiency syndrome	0.000245	0.00329	CbGeAlD
Captopril—MMP2—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.00024	0.00351	CbGpPWpGaD
Captopril—F2—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000236	0.00345	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—ALB—acquired immunodeficiency syndrome	0.000222	0.00324	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	0.000221	0.00323	CbGpPWpGaD
Captopril—MMP9—Axon guidance—ACTG1—acquired immunodeficiency syndrome	0.000221	0.00323	CbGpPWpGaD
Captopril—ABCB1—retina—acquired immunodeficiency syndrome	0.000215	0.00289	CbGeAlD
Captopril—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.00021	0.00282	CbGeAlD
Captopril—MMP9—AP-1 transcription factor network—IFNG—acquired immunodeficiency syndrome	0.000203	0.00297	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000202	0.00295	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	0.000202	0.00295	CbGpPWpGaD
Captopril—CYP2D6—blood—acquired immunodeficiency syndrome	0.0002	0.00269	CbGeAlD
Captopril—MMP9—amb2 Integrin signaling—IL6—acquired immunodeficiency syndrome	0.000199	0.0029	CbGpPWpGaD
Captopril—MMP9—TWEAK Signaling Pathway—TNF—acquired immunodeficiency syndrome	0.000198	0.00289	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000186	0.00272	CbGpPWpGaD
Captopril—MMP2—ATF-2 transcription factor network—IL6—acquired immunodeficiency syndrome	0.000186	0.00271	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000183	0.00267	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—IL2—acquired immunodeficiency syndrome	0.000181	0.00264	CbGpPWpGaD
Captopril—F2—Folate Metabolism—ALB—acquired immunodeficiency syndrome	0.00018	0.00263	CbGpPWpGaD
Captopril—MMP9—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—acquired immunodeficiency syndrome	0.000177	0.00258	CbGpPWpGaD
Captopril—MMP9—CXCR4-mediated signaling events—CD4—acquired immunodeficiency syndrome	0.00017	0.00248	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000169	0.00246	CbGpPWpGaD
Captopril—F2—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	0.000165	0.0024	CbGpPWpGaD
Captopril—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000162	0.00218	CbGeAlD
Captopril—MMP9—TWEAK Signaling Pathway—IL6—acquired immunodeficiency syndrome	0.00016	0.00233	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000158	0.00231	CbGpPWpGaD
Captopril—F2—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000158	0.00231	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—ACTG1—acquired immunodeficiency syndrome	0.000158	0.0023	CbGpPWpGaD
Captopril—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000156	0.0021	CbGeAlD
Captopril—LTA4H—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000154	0.00225	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000154	0.00225	CbGpPWpGaD
Captopril—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000153	0.00205	CbGeAlD
Captopril—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000151	0.00203	CbGeAlD
Captopril—F2—Folate Metabolism—IL2—acquired immunodeficiency syndrome	0.000146	0.00213	CbGpPWpGaD
Captopril—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000145	0.000918	CcSEcCtD
Captopril—Thrombocytopenia—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.000916	CcSEcCtD
Captopril—Malaise—Ritonavir—acquired immunodeficiency syndrome	0.000145	0.000915	CcSEcCtD
Captopril—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000914	CcSEcCtD
Captopril—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.000913	CcSEcCtD
Captopril—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.000913	CcSEcCtD
Captopril—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000912	CcSEcCtD
Captopril—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000144	0.000911	CcSEcCtD
Captopril—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000144	0.00091	CcSEcCtD
Captopril—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.00091	CcSEcCtD
Captopril—ABCB1—blood—acquired immunodeficiency syndrome	0.000144	0.00193	CbGeAlD
Captopril—Ill-defined disorder—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000906	CcSEcCtD
Captopril—F2—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	0.000143	0.00209	CbGpPWpGaD
Captopril—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000905	CcSEcCtD
Captopril—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000143	0.000903	CcSEcCtD
Captopril—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000902	CcSEcCtD
Captopril—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000143	0.000902	CcSEcCtD
Captopril—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000142	0.000898	CcSEcCtD
Captopril—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000142	0.000897	CcSEcCtD
Captopril—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000896	CcSEcCtD
Captopril—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000142	0.000896	CcSEcCtD
Captopril—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000141	0.000892	CcSEcCtD
Captopril—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000892	CcSEcCtD
Captopril—Rash—Didanosine—acquired immunodeficiency syndrome	0.000141	0.00089	CcSEcCtD
Captopril—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000141	0.000889	CcSEcCtD
Captopril—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000141	0.000889	CcSEcCtD
Captopril—Cough—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000885	CcSEcCtD
Captopril—Headache—Didanosine—acquired immunodeficiency syndrome	0.00014	0.000884	CcSEcCtD
Captopril—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.00014	0.000883	CcSEcCtD
Captopril—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00014	0.000882	CcSEcCtD
Captopril—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000881	CcSEcCtD
Captopril—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.00088	CcSEcCtD
Captopril—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000139	0.00088	CcSEcCtD
Captopril—F2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000139	0.00203	CbGpPWpGaD
Captopril—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000139	0.00187	CbGeAlD
Captopril—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000139	0.000879	CcSEcCtD
Captopril—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000139	0.000877	CcSEcCtD
Captopril—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000877	CcSEcCtD
Captopril—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000876	CcSEcCtD
Captopril—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000139	0.00186	CbGeAlD
Captopril—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000138	0.000874	CcSEcCtD
Captopril—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000138	0.000872	CcSEcCtD
Captopril—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000138	0.000871	CcSEcCtD
Captopril—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000138	0.000869	CcSEcCtD
Captopril—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000137	0.000868	CcSEcCtD
Captopril—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000137	0.000867	CcSEcCtD
Captopril—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000137	0.000866	CcSEcCtD
Captopril—ALB—Vitamin B12 Metabolism—CCL5—acquired immunodeficiency syndrome	0.000137	0.002	CbGpPWpGaD
Captopril—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000864	CcSEcCtD
Captopril—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.000864	CcSEcCtD
Captopril—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.000864	CcSEcCtD
Captopril—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.000864	CcSEcCtD
Captopril—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000136	0.000861	CcSEcCtD
Captopril—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000861	CcSEcCtD
Captopril—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000858	CcSEcCtD
Captopril—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000135	0.000854	CcSEcCtD
Captopril—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000135	0.000854	CcSEcCtD
Captopril—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000135	0.000853	CcSEcCtD
Captopril—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000853	CcSEcCtD
Captopril—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.000852	CcSEcCtD
Captopril—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000852	CcSEcCtD
Captopril—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000851	CcSEcCtD
Captopril—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000134	0.000847	CcSEcCtD
Captopril—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000134	0.000846	CcSEcCtD
Captopril—MMP9—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	0.000134	0.00195	CbGpPWpGaD
Captopril—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.000845	CcSEcCtD
Captopril—ABCB1—vagina—acquired immunodeficiency syndrome	0.000133	0.00179	CbGeAlD
Captopril—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000133	0.000842	CcSEcCtD
Captopril—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000133	0.000842	CcSEcCtD
Captopril—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000133	0.000841	CcSEcCtD
Captopril—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000133	0.00084	CcSEcCtD
Captopril—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.00084	CcSEcCtD
Captopril—F2—Angiopoietin receptor Tie2-mediated signaling—TNF—acquired immunodeficiency syndrome	0.000133	0.00194	CbGpPWpGaD
Captopril—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000133	0.000838	CcSEcCtD
Captopril—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000133	0.000838	CcSEcCtD
Captopril—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000132	0.000837	CcSEcCtD
Captopril—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000835	CcSEcCtD
Captopril—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000835	CcSEcCtD
Captopril—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000132	0.000834	CcSEcCtD
Captopril—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000132	0.000832	CcSEcCtD
Captopril—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.000831	CcSEcCtD
Captopril—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.000831	CcSEcCtD
Captopril—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.000831	CcSEcCtD
Captopril—F2—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	0.000131	0.00191	CbGpPWpGaD
Captopril—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000131	0.000826	CcSEcCtD
Captopril—F2—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	0.000131	0.00191	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000131	0.00191	CbGpPWpGaD
Captopril—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00013	0.000824	CcSEcCtD
Captopril—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000821	CcSEcCtD
Captopril—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000819	CcSEcCtD
Captopril—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000129	0.000816	CcSEcCtD
Captopril—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.000816	CcSEcCtD
Captopril—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000814	CcSEcCtD
Captopril—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000129	0.000813	CcSEcCtD
Captopril—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000813	CcSEcCtD
Captopril—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000813	CcSEcCtD
Captopril—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000129	0.000813	CcSEcCtD
Captopril—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	0.000128	0.00187	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	0.000128	0.00187	CbGpPWpGaD
Captopril—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000811	CcSEcCtD
Captopril—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000128	0.00081	CcSEcCtD
Captopril—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000128	0.00081	CcSEcCtD
Captopril—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000128	0.00081	CcSEcCtD
Captopril—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000128	0.000808	CcSEcCtD
Captopril—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000128	0.000807	CcSEcCtD
Captopril—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.000807	CcSEcCtD
Captopril—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000127	0.000804	CcSEcCtD
Captopril—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000803	CcSEcCtD
Captopril—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.0008	CcSEcCtD
Captopril—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000127	0.0008	CcSEcCtD
Captopril—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000127	0.000799	CcSEcCtD
Captopril—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.000798	CcSEcCtD
Captopril—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000126	0.000798	CcSEcCtD
Captopril—ABCB1—lung—acquired immunodeficiency syndrome	0.000126	0.00169	CbGeAlD
Captopril—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.000796	CcSEcCtD
Captopril—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000126	0.000795	CcSEcCtD
Captopril—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000793	CcSEcCtD
Captopril—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000793	CcSEcCtD
Captopril—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000793	CcSEcCtD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000125	0.00182	CbGpPWpGaD
Captopril—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.000789	CcSEcCtD
Captopril—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.000788	CcSEcCtD
Captopril—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000784	CcSEcCtD
Captopril—CYP2D6—brain—acquired immunodeficiency syndrome	0.000124	0.00167	CbGeAlD
Captopril—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000783	CcSEcCtD
Captopril—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000124	0.000783	CcSEcCtD
Captopril—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000124	0.000783	CcSEcCtD
Captopril—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000124	0.000781	CcSEcCtD
Captopril—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.00078	CcSEcCtD
Captopril—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000123	0.000779	CcSEcCtD
Captopril—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.000778	CcSEcCtD
Captopril—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000775	CcSEcCtD
Captopril—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000123	0.000775	CcSEcCtD
Captopril—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000123	0.000774	CcSEcCtD
Captopril—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000774	CcSEcCtD
Captopril—Rash—Stavudine—acquired immunodeficiency syndrome	0.000122	0.000772	CcSEcCtD
Captopril—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000122	0.000772	CcSEcCtD
Captopril—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000122	0.000772	CcSEcCtD
Captopril—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.000771	CcSEcCtD
Captopril—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000122	0.00077	CcSEcCtD
Captopril—Headache—Stavudine—acquired immunodeficiency syndrome	0.000122	0.000767	CcSEcCtD
Captopril—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000122	0.000767	CcSEcCtD
Captopril—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000766	CcSEcCtD
Captopril—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000121	0.000766	CcSEcCtD
Captopril—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.000765	CcSEcCtD
Captopril—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000121	0.000764	CcSEcCtD
Captopril—F2—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	0.000121	0.00176	CbGpPWpGaD
Captopril—Rash—Abacavir—acquired immunodeficiency syndrome	0.00012	0.000761	CcSEcCtD
Captopril—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00012	0.00076	CcSEcCtD
Captopril—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.00076	CcSEcCtD
Captopril—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.00076	CcSEcCtD
Captopril—Headache—Abacavir—acquired immunodeficiency syndrome	0.00012	0.000756	CcSEcCtD
Captopril—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000754	CcSEcCtD
Captopril—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000119	0.000754	CcSEcCtD
Captopril—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000119	0.000753	CcSEcCtD
Captopril—MMP9—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	0.000119	0.00174	CbGpPWpGaD
Captopril—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000749	CcSEcCtD
Captopril—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000748	CcSEcCtD
Captopril—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000745	CcSEcCtD
Captopril—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000744	CcSEcCtD
Captopril—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000743	CcSEcCtD
Captopril—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.00074	CcSEcCtD
Captopril—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.00074	CcSEcCtD
Captopril—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000738	CcSEcCtD
Captopril—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000738	CcSEcCtD
Captopril—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000117	0.00157	CbGeAlD
Captopril—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000736	CcSEcCtD
Captopril—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000732	CcSEcCtD
Captopril—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000116	0.00073	CcSEcCtD
Captopril—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000729	CcSEcCtD
Captopril—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000115	0.000729	CcSEcCtD
Captopril—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000115	0.000728	CcSEcCtD
Captopril—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000726	CcSEcCtD
Captopril—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000725	CcSEcCtD
Captopril—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000721	CcSEcCtD
Captopril—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000114	0.00072	CcSEcCtD
Captopril—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000114	0.000717	CcSEcCtD
Captopril—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000715	CcSEcCtD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000113	0.00165	CbGpPWpGaD
Captopril—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000714	CcSEcCtD
Captopril—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000113	0.000711	CcSEcCtD
Captopril—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.00071	CcSEcCtD
Captopril—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.00071	CcSEcCtD
Captopril—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000112	0.00151	CbGeAlD
Captopril—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000708	CcSEcCtD
Captopril—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000708	CcSEcCtD
Captopril—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.000708	CcSEcCtD
Captopril—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.000708	CcSEcCtD
Captopril—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000111	0.000704	CcSEcCtD
Captopril—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	0.000111	0.00162	CbGpPWpGaD
Captopril—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000701	CcSEcCtD
Captopril—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000701	CcSEcCtD
Captopril—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.00011	0.000693	CcSEcCtD
Captopril—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000693	CcSEcCtD
Captopril—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000688	CcSEcCtD
Captopril—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000687	CcSEcCtD
Captopril—F2—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	0.000109	0.00159	CbGpPWpGaD
Captopril—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000683	CcSEcCtD
Captopril—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000682	CcSEcCtD
Captopril—ALB—Folate Metabolism—IL4—acquired immunodeficiency syndrome	0.000108	0.00158	CbGpPWpGaD
Captopril—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000681	CcSEcCtD
Captopril—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000678	CcSEcCtD
Captopril—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000107	0.000678	CcSEcCtD
Captopril—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000107	0.000677	CcSEcCtD
Captopril—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000677	CcSEcCtD
Captopril—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000676	CcSEcCtD
Captopril—F2—Folate Metabolism—TNF—acquired immunodeficiency syndrome	0.000106	0.00155	CbGpPWpGaD
Captopril—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000106	0.000671	CcSEcCtD
Captopril—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000106	0.000671	CcSEcCtD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000106	0.00155	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000106	0.00155	CbGpPWpGaD
Captopril—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000106	0.000671	CcSEcCtD
Captopril—MMP9—AP-1 transcription factor network—IL6—acquired immunodeficiency syndrome	0.000106	0.00155	CbGpPWpGaD
Captopril—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000669	CcSEcCtD
Captopril—F2—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	0.000106	0.00154	CbGpPWpGaD
Captopril—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000106	0.000667	CcSEcCtD
Captopril—F2—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	0.000105	0.00154	CbGpPWpGaD
Captopril—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000662	CcSEcCtD
Captopril—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000661	CcSEcCtD
Captopril—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000657	CcSEcCtD
Captopril—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000655	CcSEcCtD
Captopril—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000104	0.000655	CcSEcCtD
Captopril—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000654	CcSEcCtD
Captopril—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000654	CcSEcCtD
Captopril—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000652	CcSEcCtD
Captopril—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.00065	CcSEcCtD
Captopril—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.000642	CcSEcCtD
Captopril—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000101	0.00064	CcSEcCtD
Captopril—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.000633	CcSEcCtD
Captopril—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.0001	0.000632	CcSEcCtD
Captopril—MMP9—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	9.99e-05	0.00146	CbGpPWpGaD
Captopril—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	9.97e-05	0.00063	CcSEcCtD
Captopril—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	9.97e-05	0.00063	CcSEcCtD
Captopril—Vomiting—Indinavir—acquired immunodeficiency syndrome	9.97e-05	0.00063	CcSEcCtD
Captopril—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	9.92e-05	0.000626	CcSEcCtD
Captopril—Rash—Indinavir—acquired immunodeficiency syndrome	9.89e-05	0.000624	CcSEcCtD
Captopril—Dermatitis—Indinavir—acquired immunodeficiency syndrome	9.88e-05	0.000624	CcSEcCtD
Captopril—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	9.84e-05	0.000622	CcSEcCtD
Captopril—Headache—Indinavir—acquired immunodeficiency syndrome	9.82e-05	0.00062	CcSEcCtD
Captopril—Dizziness—Efavirenz—acquired immunodeficiency syndrome	9.8e-05	0.000619	CcSEcCtD
Captopril—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	9.7e-05	0.000613	CcSEcCtD
Captopril—F2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	9.52e-05	0.00139	CbGpPWpGaD
Captopril—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	9.51e-05	0.000601	CcSEcCtD
Captopril—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	9.51e-05	0.000601	CcSEcCtD
Captopril—Vomiting—Efavirenz—acquired immunodeficiency syndrome	9.42e-05	0.000595	CcSEcCtD
Captopril—Asthenia—Ritonavir—acquired immunodeficiency syndrome	9.4e-05	0.000594	CcSEcCtD
Captopril—Dizziness—Delavirdine—acquired immunodeficiency syndrome	9.37e-05	0.000592	CcSEcCtD
Captopril—Rash—Efavirenz—acquired immunodeficiency syndrome	9.34e-05	0.00059	CcSEcCtD
Captopril—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	9.33e-05	0.000589	CcSEcCtD
Captopril—Nausea—Indinavir—acquired immunodeficiency syndrome	9.31e-05	0.000588	CcSEcCtD
Captopril—Headache—Efavirenz—acquired immunodeficiency syndrome	9.28e-05	0.000586	CcSEcCtD
Captopril—Pruritus—Ritonavir—acquired immunodeficiency syndrome	9.27e-05	0.000586	CcSEcCtD
Captopril—Asthenia—Saquinavir—acquired immunodeficiency syndrome	9.05e-05	0.000572	CcSEcCtD
Captopril—Vomiting—Delavirdine—acquired immunodeficiency syndrome	9.01e-05	0.000569	CcSEcCtD
Captopril—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	8.97e-05	0.000566	CcSEcCtD
Captopril—Rash—Delavirdine—acquired immunodeficiency syndrome	8.94e-05	0.000564	CcSEcCtD
Captopril—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	8.93e-05	0.000564	CcSEcCtD
Captopril—ABCB1—brain—acquired immunodeficiency syndrome	8.93e-05	0.0012	CbGeAlD
Captopril—Pruritus—Saquinavir—acquired immunodeficiency syndrome	8.93e-05	0.000564	CcSEcCtD
Captopril—Headache—Delavirdine—acquired immunodeficiency syndrome	8.88e-05	0.000561	CcSEcCtD
Captopril—Nausea—Efavirenz—acquired immunodeficiency syndrome	8.8e-05	0.000556	CcSEcCtD
Captopril—Dizziness—Ritonavir—acquired immunodeficiency syndrome	8.67e-05	0.000547	CcSEcCtD
Captopril—MMP9—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	8.67e-05	0.00127	CbGpPWpGaD
Captopril—Asthenia—Lamivudine—acquired immunodeficiency syndrome	8.64e-05	0.000545	CcSEcCtD
Captopril—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	8.63e-05	0.000545	CcSEcCtD
Captopril—ABCB1—lymph node—acquired immunodeficiency syndrome	8.63e-05	0.00116	CbGeAlD
Captopril—F2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	8.61e-05	0.00126	CbGpPWpGaD
Captopril—F2—Folate Metabolism—IL6—acquired immunodeficiency syndrome	8.59e-05	0.00125	CbGpPWpGaD
Captopril—Pruritus—Lamivudine—acquired immunodeficiency syndrome	8.52e-05	0.000538	CcSEcCtD
Captopril—F2—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	8.46e-05	0.00124	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	8.43e-05	0.00123	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	8.43e-05	0.00123	CbGpPWpGaD
Captopril—Nausea—Delavirdine—acquired immunodeficiency syndrome	8.42e-05	0.000532	CcSEcCtD
Captopril—Dizziness—Saquinavir—acquired immunodeficiency syndrome	8.34e-05	0.000527	CcSEcCtD
Captopril—Vomiting—Ritonavir—acquired immunodeficiency syndrome	8.33e-05	0.000526	CcSEcCtD
Captopril—Rash—Ritonavir—acquired immunodeficiency syndrome	8.26e-05	0.000522	CcSEcCtD
Captopril—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	8.26e-05	0.000521	CcSEcCtD
Captopril—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	8.24e-05	0.00052	CcSEcCtD
Captopril—Headache—Ritonavir—acquired immunodeficiency syndrome	8.21e-05	0.000519	CcSEcCtD
Captopril—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	8.2e-05	0.0012	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	8.09e-05	0.00118	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	8.09e-05	0.00118	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	8.09e-05	0.00118	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—IFNG—acquired immunodeficiency syndrome	8.02e-05	0.00117	CbGpPWpGaD
Captopril—Vomiting—Saquinavir—acquired immunodeficiency syndrome	8.02e-05	0.000507	CcSEcCtD
Captopril—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	8.01e-05	0.00117	CbGpPWpGaD
Captopril—Dizziness—Lamivudine—acquired immunodeficiency syndrome	7.96e-05	0.000503	CcSEcCtD
Captopril—Rash—Saquinavir—acquired immunodeficiency syndrome	7.95e-05	0.000502	CcSEcCtD
Captopril—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	7.95e-05	0.000502	CcSEcCtD
Captopril—F2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	7.91e-05	0.00115	CbGpPWpGaD
Captopril—Headache—Saquinavir—acquired immunodeficiency syndrome	7.9e-05	0.000499	CcSEcCtD
Captopril—Nausea—Ritonavir—acquired immunodeficiency syndrome	7.79e-05	0.000492	CcSEcCtD
Captopril—F2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	7.71e-05	0.00113	CbGpPWpGaD
Captopril—Vomiting—Lamivudine—acquired immunodeficiency syndrome	7.65e-05	0.000483	CcSEcCtD
Captopril—Rash—Lamivudine—acquired immunodeficiency syndrome	7.59e-05	0.000479	CcSEcCtD
Captopril—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	7.58e-05	0.000479	CcSEcCtD
Captopril—Headache—Lamivudine—acquired immunodeficiency syndrome	7.54e-05	0.000476	CcSEcCtD
Captopril—Nausea—Saquinavir—acquired immunodeficiency syndrome	7.49e-05	0.000473	CcSEcCtD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	7.28e-05	0.00106	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	7.15e-05	0.00104	CbGpPWpGaD
Captopril—Nausea—Lamivudine—acquired immunodeficiency syndrome	7.15e-05	0.000452	CcSEcCtD
Captopril—MMP9—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	6.99e-05	0.00102	CbGpPWpGaD
Captopril—F2—Hemostasis—IFNA1—acquired immunodeficiency syndrome	6.93e-05	0.00101	CbGpPWpGaD
Captopril—LTA4H—Metabolism—ALB—acquired immunodeficiency syndrome	6.87e-05	0.001	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—ALB—acquired immunodeficiency syndrome	6.86e-05	0.001	CbGpPWpGaD
Captopril—F2—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	6.83e-05	0.000997	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IFNG—acquired immunodeficiency syndrome	6.53e-05	0.000953	CbGpPWpGaD
Captopril—ALB—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	6.23e-05	0.000909	CbGpPWpGaD
Captopril—SLC15A1—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	6.19e-05	0.000904	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	6.16e-05	0.000899	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—IL6—acquired immunodeficiency syndrome	6.06e-05	0.000885	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	6.05e-05	0.000883	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	6.05e-05	0.000883	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL2—acquired immunodeficiency syndrome	5.8e-05	0.000847	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	5.56e-05	0.000812	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	5.55e-05	0.00081	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	5.47e-05	0.000799	CbGpPWpGaD
Captopril—F2—Hemostasis—CSF2—acquired immunodeficiency syndrome	5.42e-05	0.000792	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—TNF—acquired immunodeficiency syndrome	5.19e-05	0.000758	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	5.19e-05	0.000757	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	4.95e-05	0.000723	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	4.89e-05	0.000713	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	4.87e-05	0.00071	CbGpPWpGaD
Captopril—MMP2—Axon guidance—IL6—acquired immunodeficiency syndrome	4.75e-05	0.000694	CbGpPWpGaD
Captopril—F2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.67e-05	0.000682	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.67e-05	0.000682	CbGpPWpGaD
Captopril—SLC22A6—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	4.6e-05	0.000671	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	4.57e-05	0.000668	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	4.57e-05	0.000668	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	4.42e-05	0.000645	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	4.4e-05	0.000643	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TNF—acquired immunodeficiency syndrome	4.23e-05	0.000617	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.22e-05	0.000617	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—TNF—acquired immunodeficiency syndrome	4.2e-05	0.000613	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—IL6—acquired immunodeficiency syndrome	4.19e-05	0.000612	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—CSF2—acquired immunodeficiency syndrome	4.18e-05	0.00061	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.15e-05	0.000606	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.15e-05	0.000606	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.74e-05	0.000546	CbGpPWpGaD
Captopril—F2—Hemostasis—ALB—acquired immunodeficiency syndrome	3.53e-05	0.000516	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.48e-05	0.000508	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.43e-05	0.0005	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—IL6—acquired immunodeficiency syndrome	3.41e-05	0.000498	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—IL6—acquired immunodeficiency syndrome	3.39e-05	0.000495	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3.38e-05	0.000493	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	3.36e-05	0.00049	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	3.34e-05	0.000488	CbGpPWpGaD
Captopril—ALB—Metabolism—TAT—acquired immunodeficiency syndrome	3.26e-05	0.000476	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	3.21e-05	0.000468	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	3.18e-05	0.000464	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	3.18e-05	0.000464	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.16e-05	0.000461	CbGpPWpGaD
Captopril—SLC15A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.15e-05	0.000459	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.14e-05	0.000458	CbGpPWpGaD
Captopril—MMP9—Axon guidance—IL6—acquired immunodeficiency syndrome	3.12e-05	0.000455	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.11e-05	0.000454	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.89e-05	0.000421	CbGpPWpGaD
Captopril—F2—Hemostasis—IL2—acquired immunodeficiency syndrome	2.87e-05	0.000418	CbGpPWpGaD
Captopril—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	2.86e-05	0.000417	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.85e-05	0.000416	CbGpPWpGaD
Captopril—ALB—Metabolism—AGPS—acquired immunodeficiency syndrome	2.77e-05	0.000405	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—TNF—acquired immunodeficiency syndrome	2.76e-05	0.000402	CbGpPWpGaD
Captopril—ALB—Hemostasis—IFNA1—acquired immunodeficiency syndrome	2.75e-05	0.000402	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	2.71e-05	0.000395	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	2.69e-05	0.000393	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.61e-05	0.000381	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.45e-05	0.000358	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.45e-05	0.000358	CbGpPWpGaD
Captopril—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.43e-05	0.000355	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.42e-05	0.000353	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.38e-05	0.000348	CbGpPWpGaD
Captopril—SLC22A6—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.34e-05	0.000341	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	2.29e-05	0.000334	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—IL6—acquired immunodeficiency syndrome	2.22e-05	0.000325	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—IL2—acquired immunodeficiency syndrome	2.21e-05	0.000322	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	2.18e-05	0.000318	CbGpPWpGaD
Captopril—ALB—Hemostasis—CSF2—acquired immunodeficiency syndrome	2.15e-05	0.000314	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.87e-05	0.000273	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.84e-05	0.000268	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.81e-05	0.000264	CbGpPWpGaD
Captopril—F2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.68e-05	0.000246	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.64e-05	0.00024	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.58e-05	0.000231	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.26e-05	0.000184	CbGpPWpGaD
Captopril—ALB—Hemostasis—IL2—acquired immunodeficiency syndrome	1.14e-05	0.000166	CbGpPWpGaD
Captopril—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.06e-05	0.000155	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.72e-06	0.000142	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.67e-06	0.000141	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.4e-06	0.000108	CbGpPWpGaD
Captopril—F2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.71e-06	8.34e-05	CbGpPWpGaD
Captopril—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	4.98e-06	7.27e-05	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	4.7e-06	6.85e-05	CbGpPWpGaD
